Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)
Close on Nov 17, 2026Market cap $4.78MP/E –Yield –
Cerenome ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cerenome's ebitda for the twelve months ending Jun 30, 2026 was -$25.95M. For fiscal 2025 it was -$14.85M. The highest annual figure on record is -$2.76M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.85M | – |
| FY2024 | Dec 31, 2024 | -$13.82M | – |
| FY2023 | Dec 31, 2023 | -$12.69M | – |
| FY2022 | Dec 31, 2022 | -$19.09M | – |
| FY2021 | Dec 31, 2021 | -$12.10M | – |
| FY2020 | Dec 31, 2020 | -$9.22M | – |
| FY2019 | Dec 31, 2019 | -$2.76M | – |
| FY2018 | Dec 31, 2018 | -$6.76M | – |
| FY2017 | Dec 31, 2017 | -$18.53M | – |
| FY2016 | Dec 31, 2016 | -$18.52M | – |
| FY2015 | Dec 31, 2015 | -$14.19M | – |
| FY2014 | Dec 31, 2014 | -$31.66M | – |
| FY2013 | Dec 31, 2013 | -$29.05M | – |
| FY2012 | Dec 31, 2012 | -$27.49M | – |
| FY2011 | Dec 31, 2011 | -$28.56M | – |
| FY2010 | Dec 31, 2010 | -$24.39M | – |
| FY2009 | Dec 31, 2009 | -$19.87M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.02M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.60M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.46M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.39M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.55M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.60M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.53M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.14M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.71M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.41M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.94M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.97M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.81M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.39M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.30M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.31M | -146.1% |
| Q2 FY2020 | Jun 30, 2020 | -$2.26M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.35M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.10M | – |
| Q3 FY2019 | Sep 30, 2019 | $2.84M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.79M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.72M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.37M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.86M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.10M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.78M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.97M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.69M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.20M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.58M | – |
| Q2 FY2016 | Jun 30, 2016 | -$5.94M | – |
See a number that looks wrong?